Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome

Clinical and Experimental Rheumatology

Volumn 30, Issue 5, 2012, Pages 785-790

  Baldini, C ^a   Gallo, A ^b   Perez, P ^b   Mosca, M ^a   Alevizos, I ^b   Bombardieri, S ^a  

^a UNIVERSITY OF PISA   (Italy)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Mirnas; Primary sj gren's syndrome; Proteomics; Saliva

Indexed keywords

LA ANTIBODY; MICRORNA; RO ANTIBODY;

ANTIBODY DETECTION; ARTICLE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROTEOMICS; SALIVA ANALYSIS; SALIVA LEVEL; SJOEGREN SYNDROME;

ANIMALS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CYTOKINES; EARLY DIAGNOSIS; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEOMICS; SALIVA; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 84870282841     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. RUHL S: The scientific exploration of saliva in the post-proteomic era: from database back to basic function. Expert Rev Proteomics 2012;9:85-96.
2. BURBELO P, BAYAT A, LEBOVITZ EE, IADAROLA MJ: New technologies for studying the complexity of oral diseases. Oral Dis 2012;18:121-6.
3. GIUSTI L, BALDINI C, BAZZICHI L, BOMBARDIERI S, LUCACCHINI A: Proteomic diagnosis of Sjögren's syndrome. Expert Rev Proteomics 2007;4:757-67.
4. ALEVIZOS, I, ILLEI GG: MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease. Autoimmun Rev 2010;9:618-21.
5. LINDVALL AM, JONSSON R: The salivary gland component of Sjögren's syndrome: an evaluation of diagnostic methods. Oral Surg Oral Med Oral Pathol 1986;62:32-42.
6. MANDEL ID, BAURMASH H: Sialochemistry in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 1976;41:182-7.
7. CHING KH, BURBELO PD, GONZALEZ-BEGNE M et al.: Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjögren's Syndrome. J Dent Res 2011;90:445-9.
8. TANDON M, GALLO A, JANG SI, ILLEI GG, ALEVIZOS I: Deep sequencing of short RNAs reveals novel microRNAs in minor salivary glands of patients with Sjögren's syndrome. Oral Dis 2012;18:127-31.
9. BALDINI C, GIUSTI L, CIREGIA F: Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes. Arthritis Res Ther 2011;13:R194.
10. HU S, LOO JA, WONG DT: Human saliva proteome analysis. Ann N Y Acad Sci 2007;1098:323-9.
11. KAUFMAN E, LAMSTER IB: The diagnostic applications of saliva-a review. Crit Rev Oral Biol Med 2002;13:197-212.
12. BALDINI C, GIUSTI L, BAZZICHI L, LUCACCHINI A, BOMBARDIERI S: Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome? Autoimmun Rev 2008;7:185-91.
13. GIACOMELLI C, BAZZICHI L, GIUSTI L et al:. MALDI-TOF and SELDI-TOF analysis: "tandem" techniques to identify potential biomarker in fibromyalgia. Reumatismo 2011;63:165-70.
14. AL-TARAWNEH SK, BORDER MB, DIBBLE CF, BENCHARIT S: Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review. OMICS 2011;15:353-61.
15. VITALI C, BOMBARDIERI S, JONSSON R et al:. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
16. SCHIODT M, THORN J: Criteria for the salivary component of Sjögren's syndrome. A review. Clin Exp Rheumatol 1989;7:119-22.
17. KALK WW, VISSINK A, SPIJKERVET FK, BOOTSMA H, KALLENBERG CG, NIEUW AMERONGEN AV: Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome. Ann Rheum Dis 2001;60:1110-6.
18. KALK WW, VISSINK A, STEGENGA B, BOOTSMA H, NIEUW AMERONGEN AV, KALLENBERG CG: Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjögren's syndrome. Ann Rheum Dis 2002;61:137-44.
19. TISHLER M, YARON I, SHIRAZI I, YARON M: Saliva: an additional diagnostic tool in Sjögren's syndrome. Semin Arthritis Rheum 1997;27:173-9.
20. BEN-ARYEH H, SPIELMAN A, SZARGEL R et al:. Sialochemistry for diagnosis of Sjögren's syndrome in xerostomic patients. Oral Surg Oral Med Oral Pathol 1981;52:487-90.
21. NAHIR AM, ARYEH HB, SZARGEL R et al:. Sialochemistry in evaluating bromhexine treatment of Sjögren's syndrome. Br Med J 1979;2:833.
22. HAGHIGHAT N, AL-HASHIMI I: The status of lactoferrin and total iron binding capacity of human parotid saliva in Sjögren's syndrome. Clin Exp Rheumatol 2003;21:485-8.
23. STUCHELL RN, MANDEL ID, BAURMASH H: Clinical utilization of sialochemistry in Sjögren's syndrome. J Oral Pathol 1984;13:303-9.
24. SCULLY C: Oral parameters in the diagnosis of Sjögren's syndrome. Clin Exp Rheumatol 1989;7:113-7.
25. MILLER B, DEUTSCH O, REDLICH M et al:. Sialochemistry and Cortisol levels in patients with Sjögren's syndrome. Oral Dis 2011.
26. DANTZER R, KALIN N: Salivary biomarkers of stress: Cortisol and alpha-amylase. Psychoneuroendocrinology 2009;34:1.
27. BURBELO PD, LEAHY HP, ISSA AT et al:. Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjögren's syndrome. Autoimmunity 2009;42:515-24.
28. MARKUSSE HM, OTTEN HG, VROOM TM, SMEETS TJ, FOKKENS N, BREEDVELD FC: Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjögren's syndrome. Clin Immunol Immunopathol 1993;66:26-32.
29. HAMMI AR, AL-HASHIMI IH, NUNN ME, ZIPP M: Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome. J Oral Pathol Med 2005;34:198-203.
30. BERRA A, STERIN-BORDA L, BACMAN S, BORDA E: Role of salivary IgA in the pathogenesis of Sjögren's syndrome. Clin Immunol 2002;104:49-57.
31. MOODY M, ZIPP M, AL-HASHIMI I: Salivary anti-spectrin autoantibodies in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:322-7.
32. HE J, QIANG L, DING Y et al:. The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205-220) antibody in the saliva of patients with primary Sjögren's syndrome. Clin Exp Rheumatol 2012;30:322-6.
33. ROESCHER N, TAK PP, ILLEI GG: Cytokines in Sjögren's syndrome. Oral Dis 2009;15:519-26.
34. VAKALOGLOU KM, MAVRAGANI CP: Activation of the type I interferon pathway in primary Sjögren's syndrome: an update. Curr Opin Rheumatol 2011;23:459-64.
35. MAVRAGANI CP, CROW MK: Activation of the type I interferon pathway in primary Sjögren's syndrome. J Autoimmun 2010;35:225-31.
36. VARIN MM, LE POTTIER L, YOUINOU P, SAULEP D, MACKAY F, PERS JO: B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF. Autoimmun Rev 2010;9:604-8.
37. STRECKFUS C, BIGLER L, NAVAZESH M, AL-HASHIMI I: Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study. Clin Oral Investig 2001;5:133-5.
38. RHODUS N, DAHMER L, LINDEMANN K, RUDNEY J, MATHUR A, BEREUTER J: s-IgA and cytokine levels in whole saliva of Sjögren's syndrome patients before and after oral pilocarpine hydrochloride administration: a pilot study. Clin Oral Investig 1998;2:191-6.
39. KANG EH, LEE YJ, HYON JY, YUN PY, SONG YW: Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-alpha levels and Th-1/Th-2 ratios. Clin Exp Rheumatol 2011;29:970-6.
40. JUUSOLA J, BALLANTYNE J: mRNA profiling for body fluid identification by multiplex quantitative RT-PCR. J Forensic Sci 2007;52:1252-62.
41. PARK NJ, ZHOU H, ELASHOFF D et al:. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 2009;15:5473-7.
42. ALEVIZOS I, ILLEI GG: MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol 2010;6:391-8.
43. CHUA JH, ARMUGAM A, JEYASEELAN K: MicroRNAs: biogenesis, function and applications. Curr Opin Mol Ther 2009;11:189-99.
44. LEE Y, KIM M, HAN J et al:. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004;23:4051-60.
45. MIRANDA KC, HUYNH T, TAY Y et al:. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006;126:1203-17.
46. MICHAEL A, BAJRACHARYA SD, YUEN PS et al:. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 2010;16:34-8.
47. LIU CJ, LIN SC, YANG CC, CHENG HW, CHANG KW: Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck 2012;34:219-24.
48. GALLO A, TANDON M, ALEVIZOS I, ILLEI GG: The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 2012;7:e30679.
49. KAPSOGEORGOU EK, ABU-HELU RF, MOUTSOPOULOS HM, MANOUSSAKIS MN: Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins. Arthritis Rheum 2005;52:1517-21.
50. CASTAGNOLA M, PICCIOTTI PM, MESSANA I et al:. Potential applications of human saliva as diagnostic fluid. Acta Otorhinolaryngol Ital 2011;31:347-57.
51. HU S, JIANG J, WONG DT: Proteomic analysis of saliva: 2D gel electrophoresis, LC-MS/MS, and Western blotting. Methods Mol Biol 2010;666:31-41.
52. FERRACCIOLI G, DE SANTIS M, PELUSO G et al:. Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. Autoimmun Rev 2010:9:622-6.
53. LOO JA, YAN W, RAMACHANDRAN P, WONG DT: Comparative human salivary and plasma proteomes. J Dent Res 2010;89:1016-23.
54. FLEISSIG Y, DEUTSCH O, REICHENBERG E et al:. Different proteomic protein patterns in saliva of Sjögren's syndrome patients. Oral Dis 2009;15:61-8.
55. GIUSTI L, BALDINI C, BAZZICHI L et al:. Proteome analysis of whole saliva: a new tool for rheumatic diseases-the example of Sjögren's syndrome. Proteomics 2007;7:1634-43.
56. HU S, GAO K, POLLARD R et al:. Preclinical validation of salivary biomarkers for primary Sjögren's syndrome. Arthritis Care Res (Hoboken) 2010;62:1633-8.
57. HU S, WANG J, MEIJER J et al:. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum 2007;56:3588-600.
58. PELUSO G, DE SANTIS M, INZITARI R et al:. Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. Arthritis Rheum 2007;56:2216-22.
59. RYU OH, ATKINSON JC, HOEHN GT, ILLEI GG, HART TC: Identification of parotid salivary biomarkers in Sjögren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxford) 2006;45:1077-86.
60. ITO K, FUNAYAMA S, HITOMI Y et al:. Proteome analysis of gelatin-bound salivary proteins in patients with primary Sjögren's syndrome: identification of matrix metalloproteinase-9. Clin Chim Acta 2009;403:269-71.
61. GALLO A, BALDINI C, TEOS L, MOSCA M, BOMBARDIERI S, ALEVIZOS I: Emerging trends in Sjögren's syndrome: basic and translational research. Clin Exp Rheumatol 2012 Sep. 25 [Epub ahead of print].
62. GIUSTI L, BAZZICHI L, BALDINI C et al:. Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis. J Rheumatol 2007;34:2063-9.
63. GIUSTI L, BALDINI C, CIREGIA F et al:. Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis? Proteomics Clin Appl 2010;4:315-24.
64. XIAO H, ZHANG L, ZHOU H, LEE JM, GARON EB, WONG DT: Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteomics 2012;11:M111012112.
65. ZHANG L, XIAO H, KARLAN S et al:. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS One 2010;5:el5573.
66. DORNER T: Challenges in understanding Sjögren's syndrome-improved insights into the pathogenesis generate hope for innovative therapies? Arthritis Res Ther 2011;13:123.
67. BALDINI C et al:. A clinical prediction rule for lymphoma development in primary Sjögren's syndrome. J Rheumatol 2012;39:804-8.
68. VOULGARELIS M, SKOPOULI FN: Clinical, immunologic, and molecular factors predicting lymphoma development in Sjögren's syndrome patients. Clin Rev Allergy Immunol 2007;32:265-74.
69. THEANDER E, VASAITIS L, BAECKLUND E et al:. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann Rheum Dis 2011;70:1363-8.
70. HU S, ZHOU M, JIANG J et al:. Systems biology analysis of Sjögren's syndrome and milcosa-associated lymphoid tissue lymphoma in parotid glands. Arthritis Rheum 2009;60:81-92.
71. BALDINI C, GIUSTI L, CIREGIA F et al:. Correspondence between salivary proteomic pattern and clinical course in primary Sjögren syndrome and non-Hodgkin's lymphoma: a case report. J Transl Med 2011;9:188.